TrialJournal of hematology & oncology2016

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.

Thea Kristin Våtsveen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.